Kinase inhibition for nononcologic diseases
1. 系统已在2026-09-25 13:59:08对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接: https://www.sciencedirect.com/science/chapter/edited-volume/abs/pii/B9780443439742000094
其他信息:
Z Xie, X Hu, C Liao
Kinase Targets and Drug Discovery, 2026
Elsevier
… Cocrystal structures of abrocitinib bound to JAK1 and JAK2 … In 2021 and 2022, abrocitinib
was approved by the European … assess the efficacy of abrocitinib in alleviating severe fatigue …

